WO1993009773A1 - Composition servant a prevenir ou a traiter la dysmenorrhee et aliment ayant une fonction de prevention de la dysmenorrhee - Google Patents

Composition servant a prevenir ou a traiter la dysmenorrhee et aliment ayant une fonction de prevention de la dysmenorrhee Download PDF

Info

Publication number
WO1993009773A1
WO1993009773A1 PCT/JP1992/001507 JP9201507W WO9309773A1 WO 1993009773 A1 WO1993009773 A1 WO 1993009773A1 JP 9201507 W JP9201507 W JP 9201507W WO 9309773 A1 WO9309773 A1 WO 9309773A1
Authority
WO
WIPO (PCT)
Prior art keywords
dysmenorrhea
preventing
epa
acid
dha
Prior art date
Application number
PCT/JP1992/001507
Other languages
English (en)
Japanese (ja)
Inventor
Nisikawa Masazumi
Hisinuma Takanori
Michinao Mizugaki
Original Assignee
Taiyo Gyogyo Kabusiki Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiyo Gyogyo Kabusiki Kaisha filed Critical Taiyo Gyogyo Kabusiki Kaisha
Publication of WO1993009773A1 publication Critical patent/WO1993009773A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Definitions

  • the first invention for which a patent is sought is Eicosapenic acid
  • a composition for preventing or treating dysmenorrhea which comprises at least one or more of sahexenaic acid or a derivative thereof as an active ingredient.
  • Vitamin E ⁇ -tocopherol
  • the pharmacological effect of preventing or treating dysmenorrhea which has been considered difficult in the past, can be realized by simply administering the pharmacological effect.

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Composition servant à prévenir ou à traiter la dysménorrhée, produit préventif ou curatif contre la dysménorrhée, obtenu par l'incorporation de la composition dans une préparation pharmaceutique, et aliment ayant une fonction de prévention de la dysménorrhée. La composition contient en tant qu'ingrédient actif au moins un élément sélectionné parmi l'acide eicosapentaénoïque (EPA), l'acide docosahexaénoïque (DHA) et leurs dérivés, et se fonde sur la découverte que l'EPA et le DHA sont utiles pour traiter la dysménorrhée, notamment la dysménorrhée primaire.
PCT/JP1992/001507 1991-11-18 1992-11-18 Composition servant a prevenir ou a traiter la dysmenorrhee et aliment ayant une fonction de prevention de la dysmenorrhee WO1993009773A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP32945891A JP3177686B2 (ja) 1991-11-18 1991-11-18 月経困難症予防または治療剤と月経困難症予防機能性食品
JP3/329458 1991-11-18

Publications (1)

Publication Number Publication Date
WO1993009773A1 true WO1993009773A1 (fr) 1993-05-27

Family

ID=18221605

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP1992/001507 WO1993009773A1 (fr) 1991-11-18 1992-11-18 Composition servant a prevenir ou a traiter la dysmenorrhee et aliment ayant une fonction de prevention de la dysmenorrhee

Country Status (2)

Country Link
JP (1) JP3177686B2 (fr)
WO (1) WO1993009773A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015198054A1 (fr) * 2014-06-27 2015-12-30 The University Court Of The University Of Edinburgh Nouveau traitement pour endométriose

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54117035A (en) * 1978-01-23 1979-09-11 Verronmay Ltd Medical and food composition
JPS6216415A (ja) * 1985-07-04 1987-01-24 エフアモル・リミテツド 月経前症候群治療用医薬組成物およびその治療方法
JPS6281310A (ja) * 1985-10-02 1987-04-14 Agency Of Ind Science & Technol ガンマリノレン酸含有ドリンク剤

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54117035A (en) * 1978-01-23 1979-09-11 Verronmay Ltd Medical and food composition
JPS6216415A (ja) * 1985-07-04 1987-01-24 エフアモル・リミテツド 月経前症候群治療用医薬組成物およびその治療方法
JPS6281310A (ja) * 1985-10-02 1987-04-14 Agency Of Ind Science & Technol ガンマリノレン酸含有ドリンク剤

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015198054A1 (fr) * 2014-06-27 2015-12-30 The University Court Of The University Of Edinburgh Nouveau traitement pour endométriose

Also Published As

Publication number Publication date
JPH05139966A (ja) 1993-06-08
JP3177686B2 (ja) 2001-06-18

Similar Documents

Publication Publication Date Title
JP5441287B2 (ja) 心血管事象を予防するための必須脂肪酸
US7195914B2 (en) Composition and method for treatment of hypertriglyceridemia
Kapoor et al. Coenzyme Q10-a novel molecule
JP2008521863A (ja) Ｈｉｖ感染患者における抗レトロウイルス治療がひき起こす高コレステロール血症の治療のためのオメガ−３脂肪酸の利用
UA76108C2 (en) Use of therapeutic combination of fatty acids
KR20080024511A (ko) 심혈관 이벤트 발병 예방용 조성물
AU2001286576A1 (en) Composition and method for treatment of hypertriglyceridemia
HUE028065T2 (en) Preparations for the treatment of neurological disorders
WO2012112531A1 (fr) Statine et acides gras oméga-3 (epa, dha et dpa) utilisés dans les maladies cardiovasculaires
US8206759B2 (en) Method of reducing blood cholesterol and triglyceride levels using combinations of vasoprotective agent
JPS6377817A (ja) 治療用組成物
EP0201159A2 (fr) Compositions pharmaceutiques et diététiques contenant des acides linoléniques pour le traitement de l'hypertrophie prostatique bénigne
JPH0825876B2 (ja) 面皰治療剤組成物
WO1993009773A1 (fr) Composition servant a prevenir ou a traiter la dysmenorrhee et aliment ayant une fonction de prevention de la dysmenorrhee
WO2012112511A1 (fr) Inhibiteur de l'absorption du cholestérol (azétidinone) et acides gras oméga 3 (epa, dha, dpa) pour la réduction du cholestérol et pour la réduction des événements cardiovasculaires
AU2005244483B2 (en) Essential fatty acids in the prevention and/or treatment of depression in patients with coronary heart or artery disease
JPH04169524A (ja) 血清脂質改善作用を有する組成物
JPS5978118A (ja) 血栓症治療および予防剤
JP2007532605A5 (fr)
US9248138B2 (en) Process and composition for stabilization of vulnerable plaque utilizing a combination of a statin and omega 3 fatty acids
JP2000044470A (ja) 高脂血症薬
EP1147769A2 (fr) Utilisation d'acides gras polyinsaturés, en particulier des acides gras oméga 3, pour le traitement de l'énurésie et de l'incontinence
JPS6011421A (ja) 血中脂質降下剤
WO2015106177A1 (fr) Procédé et composition de stabilisation de plaques vulnerables à l'aide d'une combinaison composée d'une statine et d'acides gras omega 3
ZA200301525B (en) Composition and method for treatment of hypertriglyceridemia.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): SE US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase